CMPS|Compass Pathways PLC|Price:11.260|Chg%:-0.450
This article provides a detailed financial overview of Compass Pathways PLC (CMPS), including its stock performance, key financial figures, analyst ratings, and company information. CMPS is a biotechnology company focused on mental health, specifically developing its COMP360 psilocybin treatment for conditions like treatment-resistant depression. …